Deciphera Pharmaceuticals (DCPH) Tops Q1 EPS by 10c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q1 EPS of ($0.80), $0.10 better than the analyst estimate of ($0.90). Revenue for the quarter came in at $29.2 million versus the consensus estimate of $26.43 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
• Badger Meter (BMI) Tops Q1 EPS by 17c ; Provides Outlook
• Elevance Health Inc. (ELV) Tops Q1 EPS by 16c, tops guidance